書誌事項
- タイトル別名
-
- L-type amino acid transporter 1 inhibitor JPH203 as a new therapeutic target for castration resistant prostate cancer treatment
抄録
<p>L-type amino acid transporter 1 (LAT1) plays a role in transporting essential amino acids including leucine, which regulates the mTOR signaling pathway. Here, we studied the expression profile and functional role of LAT1 in prostate cancer using JPH203, a specific inhibitor of LAT1. LAT1 was highly expressed in castration-resistant prostate cancer (CRPC) cell lines including C4-2 and PC-3, while poorly expressed in castration sensitive LNCaP cells. 5 μ M of JPH203 significantly blocked 14C leucine uptake in CRPC cells, while not affected in LNCaP cells. JPH203 inhibited cell migration at 30 μ M in CRPC cells, while not affected in LNCaP cells. Combination of JPH203 30 μ M and Enzalutamide 10 μ M additively blocked the cell proliferation in CRPC cells. RNA sequence identified CD24 as a novel downstream target of JPH203 in C4-2 cells. SiCD24 blocked cell migration in C4-2 cells via blocking phosphorylation of GSK3β and activating phosphorylation of β catenin. JPH203 25mg/kg significantly inhibited tumor growth in the C4-2 xenograft nude mouse model. Targeting LAT1 by JPH203 may represent a novel therapeutic option in CRPC.</p><p></p>
収録刊行物
-
- 日本薬理学会年会要旨集
-
日本薬理学会年会要旨集 96 (0), 3-B-P-262-, 2022
公益社団法人 日本薬理学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390857512439268224
-
- ISSN
- 24354953
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
-
- 抄録ライセンスフラグ
- 使用不可